Home Sensible Biotechnologies

Sensible Biotechnologies

In operation
Donation/ Crowdfunding
Biotechnology Researcher
Basic
Enterprise Profile
LinkedIn

Basic Information

Sensible Biotechnologies is building a cell-based platform for the production of high-quality mRNA. Sensible's platform eliminates major bottlenecks in the mRNA production process, striving to unlock the full potential of mRNA technology as well as next-generation mRNA therapies and vaccines. Sensible aims to become an integral part of the global biomanufacturing infrastructure and biosecurity framework.
Sensible Biotechnologies, Inc.
Slovakia
15~50 people
January 01, 2021
info@sensible.bio

Enterprise Profile

Industrial Sector
New Drug Development Immune Cell Therapy Vaccine Formulation Production
Technology
Cell Technology
Concept
Tumor
Application Scenarios
Innovative Drugs Traditional Vaccines (Biological Products for Prevention) Nucleic Acid Drugs